Author:
Arab Rama,Kassai Behrouz,Kilo Roubi,Cornu Catherine,Gomes Elisabete,Dagonneau Tristan
Funder
Agence Nationale de Sécurité du Médicament et des Produits de Santé
Reference19 articles.
1. European Paediatric Formulation Initiative (EuPFI)-Formulating ideas for better medicines for children;Salunke;AAPS PharmSciTech,2017
2. Committee for Medicinal Products for Human Use (CHMP). Reflection paper: formulations of choice for the paediatric population. 2006. https://www.ema.europa.eu/en/documents/scientific-guideline/reflection-paper-formulations-choice-paediatric-population_en.pdf. [Accessed 17 December 2021 (45 pp.).
3. Formulation of medicines for children;Nunn;Br J Clin Pharmacol,2005
4. European Paediatric Formulation Initiative (EuPFI). Challenges of developing palatable oral paediatric formulations;Cram;Int J Pharm,2009
5. Factors influencing the acceptability of pediatric galenic formulations;Rehn;Ann Pharm Fr,2018